Clinical Trial

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures

Study acronym: SNRI
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this pilot study is to learn about the feasibility about prescribing anti-depressants at discharge in patients aged 50 years and older with a lower extremity fragility fracture. The main questions it aims to answer are: * What are the obstacles to enrolling patients and prescribing anti-depressants among older adults? * Is it possible to start prescribing SNRI medication upon discharge? * What is the prevalence of depressive symptoms amongst patients with different types of injuries and weightbearing status? * What is a transition of care plan for patients who have geriatric depression and require further care? Participants will: * Undergo screening using the Geriatric Depression Scale * Start on Duloxetine 30mg daily at time of discharge * Report medication compliance and complete re-screening monthly * Complete patient reported outcome measures and 3 months, 6 months, and 1 year * Receive a referral to behavioral health, primary care, or psychiatrist for evaluation if they screen positive at any timepoint
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2023-05-09; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2024-02-26
Trial Details
NCT Number NCT05851898
Lead Sponsor Wake Forest University Health Sciences
Conditions Depression in Old Age, Fragility Fracture
Enrollment 100 participants
Start Date 2024-04-08
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-12